Trials / Completed
CompletedNCT02313090
Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim was to assess the impact of a cell phone-based diabetes management application (Welltang) on HbA1c, blood glucose, lipids, physical activity, weight, and blood pressure during 3 months. And hypoglycemic events, the satisfaction of the patients with Boyibang, their diabetes knowledge and self-care behaviors were also evaluated.
Detailed description
At baseline, all patients completed the Diabetes Self- Care Behavior Questionnaire and a Diabetes Knowledge Survey. Health, medical and demographic history, height and weight, waist and hip circumferences, and blood pressure were recorded. HbA1c and low-density lipoprotein cholesterol (LDL-C) level were tested. All of these data were measured 3 months later at the conclusion of the study intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Welltang | The intervention group installed Welltang (downloaded from www.welltang.com for free) designed by Shanghai Geping Information and Technique Company Ltd (Shanghai, China) on their cell phones. Welltang is a cell phone- based diabetes management application that consists of three main parts: knowledge, self-management, communication between patients and clinicians |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-12-09
- Last updated
- 2014-12-09
Source: ClinicalTrials.gov record NCT02313090. Inclusion in this directory is not an endorsement.